| Antigen: |
CD5 (Leu-1) |
| Relevance: |
CD5 is a surface glycoprotein present on peripheral T cells (>95%) and B-cell chronic lymphocytic leukaemia cells that binds CD72. CD5 has utility for the monitoring of T-cell numbers in peripheral blood and the identification of leukaemias of T cell origin. Absence of the CD5 marker on childhood ALL cells is associated with a more favourable prognosis. |
| Clone: |
Y2/178 |
| Subclass: |
IgG1 |
| Applications: |
Western blot, Immunohistochemistry (Frozen sections), FACS |
| Epitope: |
Cell surface |
| Immunogen: |
Normal lymphocytes treated with PHA (phytohaemagglutinin) |
| Reactivity: |
Human |
| Species raised in: |
Mouse |
| Fusion partner: |
P3/NS1/1-Ag4-1 (NS-1) |
| Recommended growth conditions: |
RPMI 1640 + 10% FCS + penicillin (100U/ml) + streptomycin (100mg/l) + glutamine (2mM) + HAT |
| References: |
- |
| Notes: |
Please note this cell line has not been weaned out of HAT. Ultroser G can be used at 1% if the cells are not growing well |
For further information about antibodies from CRT or to discuss sales or licensing options, please contact us at reagents@cancertechnology.com
Click here to view Notes and Disclaimer information |
